| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.051 | 0.3 |